Immune checkpoint inhibitor-associated bilateral optic neuritis.
Gyan C, Bonello M, Pinto AA.
Pract Neurol. 2025 Jul 30:pn-2025-004640. doi: 10.1136/pn-2025-004640. Online ahead of print.
Paraneoplastic Encephalomyelitis.
Tirthani E, Said MS, Smith RG, Jadhav N, Shanina E.
2023 Jun 25. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–.
Consensus disease definitions for ophthalmic immune-related adverse events of immune checkpoint inhibitors.
Chang EL, Liu R, Keyhanian K, Huynh K, Berkenstock M, Bhatti MT, Chen JJ, Chodosh J, Costello F, Dalvin LA, DeLott LB, Dinkin M, Egan RA, Fraser CL, Freitag SK, Gangaputra S, Gordon LK, Guidon AC, Johnson DB, Kombo N, Kramer M, Lee AG, Levy M, Lobo-Chan AM, Mantopoulos D, Papaliodis G, Pless M, Pimkina J, Rubin KM, Sen HN, Shariff A, Subramanian PS, Tsui E, Yoon MK, McDunn J, Rine J, Reynolds KL, Sobrin L, Chwalisz BK.
J Immunother Cancer. 2025 Apr 8;13(4):e011049. doi: 10.1136/jitc-2024-011049.
Rapid Immunodot AQP4 Assay for Neuromyelitis Optica Spectrum Disorder.
Fu Y, Bi J, Yan Y, Sun X, Li K, Kim SY, Han SM, Zhou L, Li R, Huang Q, Wang N, Lin A, Kim HJ, Qiu W.
JAMA Neurol. 2023 Oct 1;80(10):1105-1112. doi: 10.1001/jamaneurol.2023.2974.
Immune-related biomarkers in the neuromyelitis optica spectrum disorder; pathogenesis and therapeutic approaches.
Li J, Dan Y, Su W, Zhao M, Chen Z, Zhao Z.
Exp Eye Res. 2025 Jul;256:110395. doi: 10.1016/j.exer.2025.110395. Epub 2025 Apr 22.
Bilateral retrobulbar optic neuritis combined with optic perineuritis associated with atezolizumab treatment for small cell lung carcinoma.
Zhang J, Wang L, Zhang L, Liu H, Yang B, Jiang L.
Eur J Ophthalmol. 2024 May;34(3):NP29-NP33. doi: 10.1177/11206721231222659. Epub 2024 Jan 5.
Isolated optic neuritis after pembrolizumab administration for non-small-cell lung carcinoma.
Makri OE, Dimitrakopoulos FI, Tsapardoni F, Tsekouras I, Argyriou AA, Kalofonos H, Georgakopoulos CD.
Int J Neurosci. 2022 Jul;132(7):643-648. doi: 10.1080/00207454.2020.1831489. Epub 2020 Oct 14.
Neuro-Ophthalmic Complications of Immune Checkpoint Inhibitors.
Garcia CR, Al-Zubidi N.
Neurol Clin. 2026 May;44(2):279-290. doi: 10.1016/j.ncl.2025.11.005. Epub 2026 Jan 27.
Neuro-ophthalmic complications of modern anti-cancer drugs.
Oskam JA, Danesh-Meyer HV.
Graefes Arch Clin Exp Ophthalmol. 2024 Jul;262(7):2269-2281. doi: 10.1007/s00417-023-06350-4. Epub 2024 Feb 12.
Treatment update for autoimmune/immune-mediated central nervous system diseases.
Wu J, Li X, Peng J, Fu W, Chen S, Wu H.
Folia Neuropathol. 2025;63(1):19-29. doi: 10.5114/fn.2025.149473.
